Sign in to view content

Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2018

Related

ASRS Presidents' Retina Young Investigators Award, Advancing Insights Into Diabetic Eye Disease, Rishi P. Singh, MD
Rishi P. Singh, MD
Annual Meeting Talks
2018
Report of the Safety and Efficacy of the Use of a Short 32-Gauge Needle for Intravitreal Anti-VEGF Injections for ROP: A Multicenter Retrospective Study
Linda A Cernichiaro- Espinosa, MD
Annual Meeting Talks
2018
Endoscopy-Assisted Vitrectomy in Complex Rhegmatogenous Retinal Detachment: Is It an Advantage?
Flavio A. Rezende, MD, PhD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more